Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

举重的风险 举重的风险

W S Breall

    JAMA
    |June 29, 1970
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Type A behavior and coronary atherosclerosis.

    Atherosclerosis·2001
    Same author

    Effect of type A behavioral counseling on frequency of episodes of silent myocardial ischemia in coronary patients.

    American heart journal·1996
    Same author

    Suggested guidelines for rating cardiac disability in workers' compensation. Medical and Chiropractic Advisory Committee to the Administrative Director of the California Division of Industrial Accidents.

    The Western journal of medicine·1993
    Same author

    Effect of discontinuance of type A behavioral counseling on type A behavior and cardiac recurrence rate of post myocardial infarction patients.

    American heart journal·1987
    Same author

    Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project.

    American heart journal·1986
    Same author

    Alteration of type A behavior and reduction in cardiac recurrences in postmyocardial infarction patients.

    American heart journal·1984
    Same journal

    Online Prescribing of GLP-1 Receptor Agonists.

    JAMA·2026
    Same journal

    Using AI Disagreement to Expose Gaps in Coverage Rules.

    JAMA·2026
    Same journal

    Randomized Trials in Pregnancy.

    JAMA·2026
    Same journal

    Randomized Trials in Pregnancy-Reply.

    JAMA·2026
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    查看所有相关文章